International Live Conference on Alzheimer's Disease
Alzheimer's Disease 2026
18 April 2026
Researchers, clinicians, and students are warmly invited to participate and present their work at Alzheimer's Disease 2026.
Submit Abstract for upcoming conferences
https://www.olcias.com/submit-abstract
Register for the Conference
https://www.olcias.com/register-conferences
About the Conference
The International Live Conference on Alzheimer's Disease – Alzheimer's Disease 2026 is a global scientific gathering dedicated to advancing knowledge, research, and collaborative action in the fight against Alzheimer's disease and related neurodegenerative disorders.
Alzheimer’s disease continues to be one of the most challenging public health concerns of our time, affecting millions of individuals and families worldwide. Rapid developments in neuroscience, biomarkers, diagnostics, and therapeutic interventions make it essential for clinicians, researchers, caregivers, and policymakers to come together to share insights and explore innovative solutions.
Alzheimer's Disease 2026 will provide a dynamic platform for experts from around the world to present cutting-edge research, discuss clinical experiences, and explore emerging technologies that are shaping the future of Alzheimer’s diagnosis, treatment, and prevention.
Through keynote lectures, scientific presentations, and collaborative discussions, the conference aims to foster interdisciplinary dialogue and accelerate progress toward better care, improved patient outcomes, and ultimately a cure.
Conference Highlights
-
Latest research in Alzheimer’s disease and neurodegeneration
-
Advances in early diagnosis and biomarkers
-
Novel therapeutic approaches and clinical trials
-
Neuroimaging and cognitive assessment innovations
-
Patient care, rehabilitation, and caregiver support
-
Public health strategies and global perspectives
Call for Abstracts
Researchers, clinicians, academicians, and healthcare professionals are warmly invited to submit abstracts presenting their latest research findings, clinical studies, or innovative approaches related to Alzheimer's disease and dementia care.
Selected abstracts will be presented during the conference sessions, providing valuable opportunities for scholarly exchange and collaboration.
Last Date for Abstract Submission:
4 April 2026
Scientific Program
The detailed Scientific Program outlining keynote speakers, session topics, and presentation schedules will be officially released on:
11 April 2026
Who Should Attend
-
Neurologists
-
Psychiatrists
-
Neuroscientists
-
Geriatricians
-
Clinical researchers
-
Healthcare professionals
-
Medical students and trainees
-
Public health experts
-
Caregivers and advocacy organizations
Looking Ahead
Building on the success of this year's meeting, the next edition of the conference:
Alzheimer's Disease 2027
will be held on
17 April 2027
This annual gathering aims to continue strengthening global collaboration and accelerating progress toward understanding and combating Alzheimer’s disease.
Join Us
We warmly invite the global scientific and medical community to participate in Alzheimer's Disease 2026 and contribute to shaping the future of Alzheimer’s research and care.
Together, through knowledge sharing and collaborative innovation, we move closer to a world where Alzheimer’s disease can be effectively prevented, treated, and ultimately cured.
Reach Us
For any inquiries regarding Alzheimer's Disease 2026, including abstract submission, participation, or general conference information, please feel free to reach out to the organising committee.
Conference Email: conferences@olcias.com
WhatsApp: +91 98182 50385
Our team will be happy to assist researchers, clinicians, students, and participants with any queries related to the conference.
Previous Year’s Distinguished Speakers & Talks
Title: Lapse Memory Deficiency in an Alzheimer’s Disease Model Using Physical and Cognitive Exercise
by Dr. Tshetiz Dahal, Lugansk State Medical University, Ukraine
by Prof. Dr. Sampoornam W, Dhanvantri College of Nursing, India
Title: Depletion of Endogenous KIF5B Ameliorates Tau hyperphosphorylation, Aggregation and Memory impairment in models of Alzheimer’s Disease
by Elias Mazrooei Rad, Biomedical Engineering Department ,Khavaran Institute of Higher Education, Iran
OLCIAS Live Conferences
OLCIAS Live Conferences
Brain Disorders 2026 International Conference | Neuroscience Research Presentations | Recorded Talks
Brain & Cognitive Science 2025 | Neuroplasticity, Glioblastoma, and Cognitive Rehabilitation
NeuroPharma 2025 | Drug Discovery for Brain Health, Mental Well-being & Neurological Disorders
